BRIEF-Sinclair IS Pharma H1 revenue rises 6.6 pct

March 25 Tue Mar 25, 2014 3:08am EDT

Related Topics

March 25 (Reuters) - Sinclair IS Pharma PLC : * Revenues growth 6.6% to £24.5 million (H1 13: £23.0 million) for the six months ended 31 December 2013 * Adjusted EBITDA* increased to £1.1 million (H1 13: £1.0 million) * Loss before tax reduced to £2.5 million (H1 13: loss of £5.8 million) * CEO says H1 results were marginally behind our expectations but these differences are now reversing * CEO says expect the full year results to be in line with our forecasts and with market expectations. * For more news, please click here

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.